Home
Abstract
My Abstract(s)
Login
ePosters
Back
Final Presentation Format
Podium Abstract
Eposter Presentation
Eposter in PDF Format
Accept format: PDF. The file size should not be more than 5MB
Eposter in Image Format
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
Presentation Date / Time
Submission Status
Submitted
Abstract
Abstract Title
Construction of a predictive model for pT3a risk in cT1 renal cell carcinoma using perioperative characteristics: a comparison of various machine learning techniques with adaptive synthetic sampling
Presentation Type
Podium Abstract
Manuscript Type
Clinical Research
Abstract Category *
Oncology: Kidney (non-UTUC)
Author's Information
Number of Authors (including submitting/presenting author) *
7
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Country
China
Co-author 1
Jingchang Mei mjc3286@163.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Co-author 2
Jingyue Liu ankhezra@gmail.com Institute of Geology and Geophysics, Chinese Academy of Sciences CAS Engineering Laboratory for Deep Resources Equipment and Technology Beijing China
Co-author 3
Yu Yao 962811311@qq.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Co-author 4
Fengju Guan gfj532@sohu.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Co-author 5
Junjie Ji shengshiyanjjj1314@163.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Co-author 6
Lijiang Sun slijiang999@126.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Co-author 7
Guiming Zhang zhangguiming9@126.com The Affiliated Hospital of Qingdao University Urology Qingdao China *
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
Co-author 16
Co-author 17
Co-author 18
Co-author 19
Co-author 20
Abstract Content
Introduction
The main objective of the present study was to develop and evaluate adaptive synthetic sampling algorithm -based machine-learning model for estimating the likelihood of upstaging to pT3a in individuals with cT1 RCC.
Materials and Methods
We conducted a retrospective analysis of 1012 patients diagnosed with clinical T1 renal cell carcinoma and treated surgically at the Affiliated Hospital of Qingdao University from June 2016 to August 2021. After randomly assigning patients to a train set and a test set in a 7:3 ratio, using adaptive synthetic sampling algorithm addressed the issue of class imbalance. LR, LASSO and RFE were applied to select features. Then, DT, SVM, RF, XGBoost and MLP methods were used to predict upstaging. The performance of the methods was evaluated by accuracy, recall rate, and area under the curve value on the test. SHAP was used to aid in the interpretation and understanding of for the optimal model.
Results
A total of 30 models were established, and through comparison, The LASSO-MLP model with the adaptive synthetic sampling algorithm train set achieved the best performance, which had the accuracy of 0.78, the AUC of 0.76 and the highest recall rate of 0.80. Compared to the original train set, the adaptive synthetic sampling algorithm train set improved the predictive performance in most of the models. SHAP analysis revealed that the tumor maximum diameter was the most important factor influencing upstaging, and other most selected features were relatively concentrated, demonstrating their value as important indicators influencing upstaging.
Conclusions
This study demonstrated the important role of machine learning could play in predicting staging to pT3a from cT1 RCC patients. The use of the adaptive synthetic sampling algorithm in the issue of upstaging could improve performance of models.
Keywords
mbalanced data, Machine learning, ADASYN, Renal cell carcinoma, TNM stage
Figure 1
https://storage.unitedwebnetwork.com/files/1237/2915de20a99e6f338c080724a63d13de.jpg
Figure 1 Caption
Flowchart of feature selection and machine learning model development process.
Figure 2
https://storage.unitedwebnetwork.com/files/1237/e299062cd32e2d1e2e31daf727c81b4f.jpg
Figure 2 Caption
The selected results of Lasso for the original train set (A and B) and the ADASYN train set (C and D). Maximum tumor diameter, Hilus involvement, necrosis and tumor edge irregular were identified as selected features in the original train set. Tumor
Figure 3
https://storage.unitedwebnetwork.com/files/1237/ceec043675557b42cba65974f04b0902.jpg
Figure 3 Caption
Features importance of the LASSO-MLP model with ADASYN (A). SHAP summary plot for input features of the LASSO-MLP model with ADASYN (B).
Figure 4
Figure 4 Caption
Figure 5
Figure 5 Caption
Character Count
1800
Vimeo Link
Presentation Details
Session
Free Paper Podium(04): Infectious Disease / Urologic Trauma
Date
Aug. 15 (Fri.)
Time
14:36 - 14:42
Presentation Order
12